Biological consequences of petite mutations in Candida glabrata
Biological consequences of petite mutations in Candida glabrata
复制标题
DOI:
10.1093/jac/dki200
复制
发表时间:
2005-08-01
影响因子:
5.2
通讯作者:
Bouchara, JP
中科院分区:
文献类型:
--
作者:
Brun, S;Dalle, F;Bouchara, JP
Objectives: To define the pathogenicity of respiration-deficient mutants of Candida glabrata, which present a reduced susceptibility to azoles, that are easily induced in vitro by exposure to these drugs or to ethidium bromide and that may be selected in vivo in patients receiving fluconazole.Methods: Two wild-type isolates of C. glabrata were compared with their respective fluconazole- or ethidium bromide-induced petite mutants, regarding the carbohydrate and protein composition of the cellwall, as well as their surface physical properties, and also their adherence abilities and virulence in mice.Results: Flow cytometric analysis of cell wall carbohydrates using several fluorescent lectins showed an increased binding of mutant cells to concanavalin A compared with their parent isolates, suggesting a greater availability or an increased amount of glucose-mannose residues at the cell surface in petite mutants. Likewise, some quantitative differences between parent and mutant isolates were shown by SDS-PAGE in protein extracts from blastoconidia. Regarding the surface physical properties, no significant differences were seen in the electrophoretic mobility determined by microelectrophoresis, but the two-phase partitioning method revealed a lower cell surface hydrophobicity for petite mutants. Moreover, mutant cells exhibited significant overexpression of CgEPA1 as revealed by real-time reverse transcription-PCR, but the adherence capacities to Caco-2 cells, a human enterocyte line, were not significantly different. Finally, in agreement with their slower growth, petite mutants were less virulent than parent isolates in a murine model of systemic infection.Conclusion: This low virulence in mice suggests that petite mutants could be disregarded clinically although they may arise during fluconazole therapy.